Will Craft
Free
The ten-year period of erosion that followed the doubling of the NIH budget has hit some research institutions harder than others.
Two years ago, British authorities tested a shipment of chemotherapy drugs headed for North America.
The American Association for Cancer Research urged FDA to regulate high-risk laboratory-developed tests, a category of assays that has escaped scrutiny because of loopholes in the regulatory process.
The Oregon Health & Science University Knight Cancer Institute moved one step closer to meeting a spectacular fundraising goal.
The Patient-Centered Outcomes Research Institute approved $54.8 million for 33 clinical effectiveness projects.
The surgeon general issued a call to action this week, addressing the rising epidemic of skin cancer in the U.S. and around the world.
